Last viewed:
XENE
Prices are updated after-hours
XENE
|
$39.46
-3.97%
-4.13%
330K
|
Health Technology
(0.0% 1d)
(-7.4% 1m)
(-0.1% 1y)
(0.0% 2d)
(-3.9% 3d)
(-1.0% 7d)
(0.63%
volume)
Earnings Calendar: 2024-02-28
Market Cap: $ 2,976,565,740
http://www.xenon-pharma.com
Sec
Filling
|
Patents
| 104 employees
(CA) Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.
nervous system
neurological
add to watch list
Paper trade
email alert is off
Press-releases
Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting
Published: 2024-04-16
(Crawled : 13:00)
- globenewswire.com
XENE
|
$39.46
-3.97%
-4.13%
330K
|
Health Technology
| -4.38%
| O: 0.0%
H: 1.73%
C: 0.44%
xen1101
neurology
pharmaceuticals
meeting
Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Published: 2024-04-10
(Crawled : 12:30)
- globenewswire.com
XENE
|
$39.46
-3.97%
-4.13%
330K
|
Health Technology
| -8.2%
| O: -1.05%
H: 1.69%
C: -0.35%
conference
pharmaceuticals
Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-04
(Crawled : 20:00)
- globenewswire.com
XENE
|
$39.46
-3.97%
-4.13%
330K
|
Health Technology
| -6.42%
| O: -0.4%
H: 1.57%
C: 0.5%
conference
pharmaceuticals
Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days
Published: 2024-03-12
(Crawled : 20:00)
- globenewswire.com
XENE
|
$39.46
-3.97%
-4.13%
330K
|
Health Technology
| -10.73%
| O: 0.34%
H: 1.7%
C: 1.53%
pharmaceuticals
Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024
Published: 2024-03-05
(Crawled : 21:00)
- globenewswire.com
XENE
|
$39.46
-3.97%
-4.13%
330K
|
Health Technology
| -14.13%
| O: 0.0%
H: 3.13%
C: -0.09%
conference
biopharma
pharmaceuticals
global
Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-02-29
(Crawled : 21:00)
- globenewswire.com
XENE
|
$39.46
-3.97%
-4.13%
330K
|
Health Technology
| -16.31%
| O: 5.3%
H: 2.6%
C: -5.75%
year
update
pharmaceuticals
financial
results
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update
Published: 2024-02-22
(Crawled : 21:00)
- globenewswire.com
XENE
|
$39.46
-3.97%
-4.13%
330K
|
Health Technology
| -19.8%
| O: -0.08%
H: 0.61%
C: 0.51%
conference
year
update
pharmaceuticals
financial
results
Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2024
Published: 2024-01-08
(Crawled : 13:00)
- globenewswire.com
XENE
|
$39.46
-3.97%
-4.13%
330K
|
Health Technology
| -13.19%
| O: -0.53%
H: 6.05%
C: 5.79%
pharmaceuticals
key
milestone
Xenon Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-03
(Crawled : 14:00)
- globenewswire.com
XENE
|
$39.46
-3.97%
-4.13%
330K
|
Health Technology
| -12.05%
| O: -0.47%
H: 0.47%
C: -1.14%
conference
pharmaceuticals
Xenon Pharmaceuticals Announces Closing of $345.0 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Published: 2023-12-04
(Crawled : 21:00)
- globenewswire.com
XENE
|
$39.46
-3.97%
-4.13%
330K
|
Health Technology
| 4.61%
| O: 0.4%
H: 2.35%
C: 2.19%
offering
pharmaceuticals
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount
0000950170-24-030250
4
2024-03-12
2024-03-11
Buy
A
100000
100000
0000950170-24-030245
4
2024-03-12
2024-03-11
Buy
A
100000
100000
0000950170-24-030239
4
2024-03-12
2024-03-11
Buy
A
100000
100000
0000950170-24-030236
4
2024-03-12
2024-03-11
Buy
A
65000
65000
0000950170-24-030233
4
2024-03-12
2024-03-11
Buy
A
65000
65000